Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/19/2025

Management of Febrile Non-Hemolytic Transfusion Reaction

Immediate Actions Upon Fever Detection

  • The American Society of Anesthesiologists recommends stopping the transfusion immediately and maintaining IV access with normal saline while assessing for signs of more serious transfusion reactions before confirming this is a simple febrile non-hemolytic reaction 1, 2
  • The American College of Physicians suggests verifying patient identification and blood component compatibility labels for clerical errors 2
  • The American Association of Blood Banks recommends notifying the transfusion laboratory/blood bank immediately 2
  • Assess vital signs including heart rate, blood pressure, respiratory rate, oxygen saturation, and repeat temperature, as recommended by the American Heart Association 1, 2
  • Perform focused assessment for additional symptoms that indicate serious reactions, such as hypotension, tachycardia, respiratory distress, and hemodynamic instability, as suggested by the American College of Emergency Physicians 2

Critical Risk Stratification

  • Fever with hypotension or tachycardia suggests acute hemolytic reaction or bacterial contamination requiring immediate aggressive management, according to the American College of Cardiology 2
  • Respiratory symptoms within 1-6 hours may indicate TRALI, one of the top three causes of transfusion-related deaths, as reported by the National Institutes of Health 2
  • Fever within 6 hours after platelet transfusion is particularly concerning for bacterial contamination, as noted by the Centers for Disease Control and Prevention 2

Diagnostic Workup

  • Send the blood component bag with administration set back to the transfusion laboratory for analysis, as recommended by the American Association of Blood Banks 2
  • Collect post-reaction blood samples for repeat crossmatch and direct antiglobulin test (Coombs test), as suggested by the American Society of Clinical Pathologists 2
  • Obtain complete blood count, as recommended by the American Society of Hematology 2
  • Perform visual inspection of plasma for hemolysis, as noted by the American Association of Blood Banks 2
  • Check urine analysis for hemoglobinuria, as suggested by the American Society of Nephrology 2
  • Obtain blood cultures before antibiotics if bacterial contamination is suspected, as recommended by the Infectious Diseases Society of America 2

Treatment for Confirmed FNHTR

  • For isolated fever without concerning features, administer intravenous paracetamol (acetaminophen) only, as recommended by the American Academy of Pediatrics 1
  • Give acetaminophen 650-1000 mg orally or IV for fever control, as suggested by the American Society of Health-System Pharmacists 2
  • Avoid repeated doses of steroids as they may further suppress immunity in immunocompromised patients, as noted by the American College of Rheumatology 1
  • Use a personalized approach tailored to symptoms: febrile reactions require only paracetamol, while allergic reactions require only antihistamines, as recommended by the American Academy of Allergy, Asthma, and Immunology 1

Management of Serious Reactions (If Present)

  • Provide oxygen, fluid resuscitation, and vasopressors if hemodynamic instability develops, as recommended by the American Heart Association 2
  • Initiate broad-spectrum antibiotics immediately after blood cultures for suspected bacterial contamination, as suggested by the Infectious Diseases Society of America 2
  • Maintain urine output >100 mL/hour with aggressive fluid resuscitation for suspected hemolytic reaction, as noted by the American Society of Nephrology 2
  • Follow local anaphylaxis protocols if severe reaction or anaphylaxis is suspected, as recommended by the American Academy of Allergy, Asthma, and Immunology 1

Prevention of Future Reactions

  • Leukoreduction significantly reduces febrile non-hemolytic reactions and should be used for all blood products, as recommended by the American Association of Blood Banks 3, 4, 5
  • Reserve premedication only for patients with documented severe allergic reactions requiring prevention, as suggested by the American College of Allergy, Asthma, and Immunology 5

Critical Pitfalls to Avoid

  • Never restart the transfusion before laboratory clearance, even if symptoms improve, as the reaction may worsen with continued exposure, as noted by the American Association of Blood Banks 2
  • Do not continue transfusion despite "just fever"—serious reactions can present subtly in anesthetized or critically ill patients, as recommended by the American Society of Anesthesiologists 2
  • Avoid assuming premedication prevents serious reactions like TRALI, TACO, or hemolytic reactions, as suggested by the American College of Emergency Physicians 5
  • In neutropenic patients, fever may be masked by scheduled NSAIDs/acetaminophen, so maintain high suspicion even with minimal symptoms, as noted by the American Society of Clinical Oncology 2

REFERENCES

2

Fever During Blood Transfusion: Immediate Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

cancer- and chemotherapy-induced anemia. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

5

Prevention of Blood Transfusion Reactions [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025